PHC3 and cancer: We found that the acquisition of strong PH3 resistance necessitates the avoidance of OXPHOS via the introduction of a few non-synonymous mutations in mitochondrial genes encoding ND as well as nuclear genes encoding DLD, concomitant with metabolic reprogramming, a recognized hallmark of cancer metabolism.